Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy

Chunguang Guo1, Zaoqu Liu2, Can Cao3

  • 1Department of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Insights

A new eight-gene model accurately predicts ischemic events after carotid endarterectomy (CEA) in patients with carotid artery stenosis. This discovery aids in preventing recurrent ischemic events and improving patient management post-surgery.

Area of Science:

  • Genomics and Bioinformatics
  • Cardiovascular Surgery
  • Translational Medicine

Background:

  • Ischemic events following carotid endarterectomy (CEA) for carotid artery stenosis are unpredictable and concerning.
  • There is a critical need for a predictive model to mitigate recurrent ischemic events post-CEA.

Purpose of the Study:

  • To develop and validate a novel predictive model for ischemic events after carotid endarterectomy (CEA).
  • To identify key genes associated with ischemic event risk in patients undergoing CEA.

Main Methods:

  • Weighted gene co-expression network analysis (WGCNA) and transcriptome correlation analysis on peripheral blood mononuclear cells from 98 patients.
  • Random forest and LASSO logistic regression algorithms to identify predictive genes and establish a diagnostic model.
  • Validation in independent cohorts using RT-qPCR, GSEA, ssGSEA, CIBERSORT, and MCP-counter analyses.

Main Results:

  • An eight-gene predictive model (PLSCR1, ECRP, CASP5, SPTSSA, MSRB1, BCL6, FBP1, LST1) was established with high accuracy (ROC-AUCs ranging from 0.792 to 0.891).
  • The model demonstrated consistent performance across training, validation, and independent cohorts.
  • High-risk patients exhibited enhanced immune signatures, suggesting potential benefits from immunotherapy.

Conclusions:

  • A highly accurate eight-gene model for predicting post-CEA ischemic events has been developed.
  • This model serves as a promising tool for enhanced clinical management and postoperative surveillance of patients with carotid artery stenosis.
  • The identified immune signatures in high-risk patients may guide future therapeutic strategies, including immunotherapy.